Max Healthcare Plans ₹1,400 Cr Lucknow Hospital Expansion, Proposes ₹2 Dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Max Healthcare Plans ₹1,400 Cr Lucknow Hospital Expansion, Proposes ₹2 Dividend
Overview

Max Healthcare's board approved a significant ₹1,400 Cr expansion for a new hospital in Lucknow, recommended a ₹2 per share dividend for FY 2025-26, and plans to move its registered office to Gurugram. These moves aim to boost capacity and reward shareholders.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Max Healthcare Institute Ltd. announced important board decisions made on May 21, 2026.

Lucknow Hospital Expansion and Dividend Approved

The company's Board of Directors reviewed the financial results for the fiscal year ending March 31, 2026. They recommended a final dividend of ₹2 per equity share, pending shareholder approval at the annual general meeting.

A substantial capital investment of approximately ₹1,400 Cr was approved for the first phase of a new Max Super Specialty Hospital in Lucknow, situated on Shaheed Path. This new facility is set to add about 712 beds and is expected to be completed within 36 months of receiving necessary approvals.

In other key decisions, the board agreed to relocate the company's registered office from Mumbai to Max Hospital in Gurugram, Haryana. This change requires member and regulatory approval.

Additionally, the board approved the reappointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the fiscal year 2026-27 and extended Mr. Anil Kumar Bhatnagar's term as Non-Executive Director for another three years, effective October 1, 2026.

Focus on Growth and Shareholder Returns

These strategic decisions underscore Max Healthcare's commitment to expanding its operational capacity and enhancing shareholder value. The large-scale investment in Lucknow is designed to meet rising healthcare demands and strengthen the company's market position.

The company, a prominent operator of multi-specialty hospitals in India, has a history of network expansion and service quality.

What's Next for Investors

Shareholders can anticipate the proposed ₹2 dividend, subject to final approval. The Lucknow hospital development represents a significant long-term growth initiative, set to increase the company's overall bed capacity. The registered office relocation is primarily an administrative change.

Potential Risks

Investors should monitor potential execution challenges with the Lucknow construction project, possible delays in regulatory approvals for the office move, and the company's success in generating returns from the new hospital infrastructure.

Competitive Landscape

Max Healthcare's expansion plans align with broader industry trends, as competitors like Apollo Hospitals and Fortis Healthcare also focus on network growth and service improvements.

Key Dates

The financial year ending March 31, 2026, covers the reported results and dividend. The Lucknow hospital's first phase is targeted for completion within 36 months of drawing approvals. The new director's term begins October 1, 2026.

Shareholders will be watching construction progress, dividend payout finalization, and the office relocation process. Disclosures regarding the re-classification of Radiant Life Care Hospital Foundation are also relevant.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.